We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$145B
AUM Growth
+$1.75B
Cap. Flow
+$4.48B
Cap. Flow %
3.09%
Top 10 Hldgs %
12.04%
Holding
10,318
New
561
Increased
3,567
Reduced
4,243
Closed
1,509

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.78%
2 Financials 9.08%
3 Energy 8.3%
4 Healthcare 7.2%
5 Technology 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWX icon
8351
Avalon Holdings
AWX
$10.1M
$2K ﹤0.01%
654
-1,176
-64% -$3.53K
BCH icon
8352
Banco de Chile
BCH
$20.9B
$2K ﹤0.01%
76
-2,504
-97% -$51.7K
BXC icon
8353
BlueLinx
BXC
$588M
$2K ﹤0.01%
201
-469
-70% -$5.04K
CDC icon
8354
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$720M
$2K ﹤0.01%
65
-69
-51% -$2.52K
CERS icon
8355
CALL
Cerus
CERS
$536M
$2K ﹤0.01%
500
CIVB icon
8356
Civista Bancshares
CIVB
$566M
$2K ﹤0.01%
166
CNP icon
8357
CALL
CenterPoint Energy
CNP
$25.4B
$2K ﹤0.01%
100
-4,900
-98% -$107K
CORN icon
8358
CALL
Teucrium Corn Fund
CORN
$152M
$2K ﹤0.01%
100
-14,900
-99% -$383K
CPRX
8359
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$2K ﹤0.01%
500
+200
+67% +$721
DXD icon
8360
CALL
ProShares UltraShort Dow 30
DXD
$52.2M
$2K ﹤0.01%
5
-60
-92% -$25.8K
DXR icon
8361
Daxor
DXR
$67.9M
$2K ﹤0.01%
+316
New +$2.01K
EDU icon
8362
CALL
New Oriental
EDU
$8.84B
$2K ﹤0.01%
100
-300
-75% -$6.03K
EFOI icon
8363
Energy Focus
EFOI
$16.6M
$2K ﹤0.01%
+12
New +$1.98K
ELDN icon
8364
Eledon Pharmaceuticals
ELDN
$215M
$2K ﹤0.01%
1
-6
-86% -$13.2K
EXAS
8365
CALL
DELISTED
Exact Sciences
EXAS
$2K ﹤0.01%
100
-1,100
-92% -$27.9K
FBIO icon
8366
Fortress Biotech
FBIO
$83.7M
$2K ﹤0.01%
39
-168
-81% -$7K
FIVN icon
8367
FIVE9
FIVN
$2.58B
$2K ﹤0.01%
407
-4,083
-91% -$17.7K
FWDI
8368
Forward Industries Inc
FWDI
$458M
$2K ﹤0.01%
+249
New +$2.32K
HEPA
8369
DELISTED
Hepion Pharmaceuticals
HEPA
0
HROW icon
8370
Harrow
HROW
$1.24B
$2K ﹤0.01%
242
-2,627
-92% -$20.1K
IMMP
8371
Immutep
IMMP
$46.7M
$2K ﹤0.01%
992
+41
+4% +$113
INSG icon
8372
Inseego
INSG
$67M
$2K ﹤0.01%
50
-902
-95% -$44K
IOR
8373
Income Opportunity Realty Investors
IOR
$2K ﹤0.01%
+312
New +$2.02K
LIVE icon
8374
Live Ventures
LIVE
$24.2M
$2K ﹤0.01%
124
-1,069
-90% -$19.7K
LND
8375
BrasilAgro
LND
$358M
$2K ﹤0.01%
818
+773
+1,718% +$2.33K

Similar funds

UBS Group's Q1 2015 Portfolio in Review

As of Q1 2015, UBS Group held 10,318 positions worth $145B, up 1.2% from $143B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

UBS Group deployed $4.48B of net new capital in Q1 2015, opening 561 new positions and adding to 3,567 existing holdings. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 200,030 shares worth $202M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Qualcomm, an estimated $294M trimmed.

  • UBS Group's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 200,030 shares worth $202M.
  • UBS Group added most to Yum! Brands in Q1 2015, an estimated $674M increase.
  • UBS Group's biggest Q1 2015 reduction was Qualcomm, cutting an estimated $294M.
  • UBS Group fully exited Allergan Inc in Q1 2015, selling an estimated $210M.
  • UBS Group's ten largest holdings make up 12% of its $145B portfolio in Q1 2015.
  • UBS Group opened 561 new positions and closed 1,509 in Q1 2015.
  • UBS Group's portfolio value rose 1.2% quarter-over-quarter to $145B.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.